Envista (NYSE:NVST) Issues FY 2026 Earnings Guidance

by · The Markets Daily

Envista (NYSE:NVST – Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.500-1.550 for the period, compared to the consensus earnings per share estimate of 1.430. The company issued revenue guidance of -.

Envista Stock Performance

Shares of NVST stock traded up $0.55 during trading on Wednesday, hitting $28.51. The company’s stock had a trading volume of 6,998,014 shares, compared to its average volume of 2,798,520. The business has a fifty day moving average of $25.87 and a 200-day moving average of $25.99. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. Envista has a 52 week low of $18.77 and a 52 week high of $30.42. The company has a market cap of $4.64 billion, a PE ratio of 69.54, a P/E/G ratio of 1.58 and a beta of 0.86.

Envista (NYSE:NVST – Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. During the same period in the previous year, the business posted $0.26 EPS. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, research analysts anticipate that Envista will post 1.42 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on NVST shares. BMO Capital Markets assumed coverage on shares of Envista in a report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price target on the stock. Robert W. Baird raised their price objective on shares of Envista from $30.00 to $31.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. Wall Street Zen lowered shares of Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 9th. Piper Sandler raised their price objective on shares of Envista from $25.00 to $26.00 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. Finally, Weiss Ratings cut shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Six research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, Envista currently has an average rating of “Hold” and an average price target of $28.62.

Read Our Latest Research Report on Envista

Hedge Funds Weigh In On Envista

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NVST. Caitong International Asset Management Co. Ltd grew its position in shares of Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares during the period. UMB Bank n.a. raised its position in shares of Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after purchasing an additional 636 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after buying an additional 949 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Envista by 378.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock valued at $47,000 after buying an additional 1,909 shares in the last quarter. Finally, Parallel Advisors LLC boosted its holdings in Envista by 13.1% in the 4th quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock worth $69,000 after buying an additional 367 shares during the last quarter.

About Envista

(Get Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

See Also